Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 2;222(6):e20231107.
doi: 10.1084/jem.20231107. Epub 2025 Mar 28.

Breast cancer gene-1 (BRCA1) potentiates maladaptive repair after kidney injury

Affiliations

Breast cancer gene-1 (BRCA1) potentiates maladaptive repair after kidney injury

Amrendra K Ajay et al. J Exp Med. .

Abstract

Maladaptive repair following kidney tubular injury leads to the development of interstitial fibrosis, a pathology common to chronic kidney diseases (CKD). Dysfunctional DNA damage response plays an important role in the progression of CKD. We found that BRCA1 expression was increased in the kidneys of patients with CKD and fibrotic kidneys of mice. Exon 11 deletion of Brca1 in proximal tubule cells (PTCs) of mice subjected to ischemic or nephrotoxic (aristolochic acid) injury resulted in a reduced number of senescent cells, as assessed by a decrease in phospho-histone H3, p16INK4a, RAD51 recruitment, G2/M cell cycle phase cells, GATA4, and senescence-associated β-galactosidase. There was less production of inflammatory profibrotic mediators and reduced kidney fibrosis. After cisplatin exposure in vitro, human PTCs with reduced BRCA1 had increased apoptosis, decreased RAD51 nuclear foci, and fewer cells in the G2/M cell cycle phase, with reduced IL-6 and sonic hedgehog production. Thus, BRCA1 regulates nonmalignant tissue responses to kidney injury, a role hitherto unrecognized.

PubMed Disclaimer

Conflict of interest statement

Disclosures: J.V. Bonventre reported personal fees from AstraZeneca, personal fees from Mitsubishi Tanabe, and "other" from MediBeacon during the conduct of the study; in addition, J.V. Bonventre had a patent to KIM-1 patents assigned to Mass General Brigham licensed “R and D.” No other disclosures were reported.

References

    1. Ajay, A.K., Kim T.-M., Ramirez-Gonzalez V., Park P.J., Frank D.A., and Vaidya V.S.. 2014. A bioinformatics approach identifies signal transducer and activator of transcription-3 and checkpoint kinase 1 as upstream regulators of kidney injury molecule-1 after kidney injury. J. Am. Soc. Nephrol. 25:105–118. 10.1681/ASN.2013020161 - DOI - PMC - PubMed
    1. Ajay, A.K., Saikumar J., Bijol V., and Vaidya V.S.. 2012. Heterozygosity for fibrinogen results in efficient resolution of kidney ischemia reperfusion injury. PLoS One. 7:e45628. 10.1371/journal.pone.0045628 - DOI - PMC - PubMed
    1. Aprelikova, O.N., Fang B.S., Meissner E.G., Cotter S., Campbell M., Kuthiala A., Bessho M., Jensen R.A., and Liu E.T.. 1999. BRCA1-associated growth arrest is RB-dependent. Proc. Natl. Acad. Sci. USA. 96:11866–11871. 10.1073/pnas.96.21.11866 - DOI - PMC - PubMed
    1. Arizti, P., Fang L., Park I., Yin Y., Solomon E., Ouchi T., Aaronson S.A., and Lee S.W.. 2000. Tumor suppressor p53 is required to modulate BRCA1 expression. Mol. Cell. Biol. 20:7450–7459. 10.1128/MCB.20.20.7450-7459.2000 - DOI - PMC - PubMed
    1. Baisantry, A., Bhayana S., Wrede C., Hegermann J., Haller H., Melk A., and Schmitt R.. 2016. The impact of autophagy on the development of senescence in primary tubular epithelial cells. Cell Cycle. 15:2973–2979. 10.1080/15384101.2016.1234547 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources